Globeflex Capital’s Elevance Health ELV Stock Holding History

Globeflex Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,227	Closed	-$5.32M	–	451
2024 Q3	$5.32M	Hold	10,227	–	–	0.51%	49
2024 Q2	$5.54M	Hold	10,227	–	–	0.58%	43
2024 Q1	$5.3M	Hold	10,227	–	–	0.52%	46
2023 Q4	$4.82M	Buy	10,227 +5	+0%	+$2.31K	0.49%	48
2023 Q3	$4.45M	Hold	10,222	–	–	0.52%	49
2023 Q2	$4.54M	Hold	10,222	–	–	0.51%	54
2023 Q1	$4.7M	Hold	10,222	–	–	0.57%	42
2022 Q4	$5.24M	Buy	10,222 +5,400	+112%	+$2.74M	0.66%	34
2022 Q3	$2.19M	Buy	4,822 +4,804	+26,689%	+$2.3M	0.38%	80
2022 Q2	$9K	Hold	18	–	–	﹤0.01%	426
2022 Q1	$9K	Hold	18	–	–	﹤0.01%	426
2021 Q4	$8K	Hold	18	–	–	﹤0.01%	416
2021 Q3	$7K	Hold	18	–	–	﹤0.01%	411
2021 Q2	$7K	Hold	18	–	–	﹤0.01%	428
2021 Q1	$6K	Hold	18	–	–	﹤0.01%	427
2020 Q4	$6K	Hold	18	–	–	﹤0.01%	439
2020 Q3	$5K	Hold	18	–	–	﹤0.01%	438
2020 Q2	$5K	Buy	+18	New	+$4.8K	﹤0.01%	462
2016 Q3	–	Sell	-398	Closed	-$52K	–	499
2016 Q2	$52K	Hold	398	–	–	0.01%	353
2016 Q1	$55K	Hold	398	–	–	0.01%	348
2015 Q4	$55K	Hold	398	–	–	0.01%	338
2015 Q3	$56K	Hold	398	–	–	0.01%	398
2015 Q2	$65K	Buy	+398	New	+$63.6K	0.01%	397

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Globeflex Capital's ELV Position: Q4 2024 in Review

Globeflex Capital sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 10,227 shares — an estimated $5.32M sold.

Globeflex Capital first reported a position in ELV in Q2 2015 and held it in 23 quarters. The position peaked at $5.54M in Q2 2024. 1,606 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Globeflex Capital reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Globeflex Capital sold 10,227 Elevance Health shares in Q4 2024, an estimated $5.32M.
Globeflex Capital first reported a position in Elevance Health in Q2 2015 and held it in 23 quarters.
Globeflex Capital's Elevance Health position peaked at $5.54M in Q2 2024.
1,606 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.